Back to Search
Start Over
Randomized phase II study of erlotinib combined with bevacizumab compared with bevacizumab alone in metastatic renal cell cancer.
- Source :
- Journal of Clinical Oncology; 10/10/2007, Vol. 25 Issue 29, p4536-4541, 6p
- Publication Year :
- 2007
Details
- Language :
- English
- ISSN :
- 0732183X
- Volume :
- 25
- Issue :
- 29
- Database :
- Supplemental Index
- Journal :
- Journal of Clinical Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 105962213